Difficulty: Medium
Average Score: 93%
Practice
Which of the following are antagonist and agonist pairs for the same receptor:
Correct answer
A
Rationale
In pharmacology, understanding the concepts of antagonist and agonist pairs is crucial for safe and effective medication management across the lifespan. In the provided question, option A (butoxamine, terbutaline) is the correct answer as they are indeed antagonist and agonist pairs for the same receptor, the beta-adrenergic receptor.
Butoxamine is a beta-adrenergic antagonist (specifically a selective beta-2 antagonist), while terbutaline is a beta-adrenergic agonist (selective beta-2 agonist). This pair works in opposite ways on the beta-adrenergic receptor, with butoxamine blocking the receptor and terbutaline stimulating it.
Option B (phenyoxybenzamine, cyclopentolate) is incorrect as they do not act on the same receptor. Phenyoxybenzamine is an alpha-adrenergic antagonist, while cyclopentolate is an anticholinergic agent.
Option C (pilocarpine, bethanechol) is also incorrect as they are both cholinergic drugs, but they do not work on the same receptor. Pilocarpine is a muscarinic agonist, while bethanechol is a muscarinic agonist with more selectivity for the GI tract.
Option D (oxymetazoline, dobutamine) is incorrect as they target different receptors. Oxymetazoline is an alpha-adrenergic agonist used for nasal decongestion, while dobutamine is a beta-adrenergic agonist primarily used for cardiac support.
Understanding antagonist and agonist pairs is essential for healthcare professionals to make informed decisions when selecting medications for patients of all ages. This knowledge helps in predicting drug effects, managing adverse reactions, and optimizing therapeutic outcomes.
Butoxamine is a beta-adrenergic antagonist (specifically a selective beta-2 antagonist), while terbutaline is a beta-adrenergic agonist (selective beta-2 agonist). This pair works in opposite ways on the beta-adrenergic receptor, with butoxamine blocking the receptor and terbutaline stimulating it.
Option B (phenyoxybenzamine, cyclopentolate) is incorrect as they do not act on the same receptor. Phenyoxybenzamine is an alpha-adrenergic antagonist, while cyclopentolate is an anticholinergic agent.
Option C (pilocarpine, bethanechol) is also incorrect as they are both cholinergic drugs, but they do not work on the same receptor. Pilocarpine is a muscarinic agonist, while bethanechol is a muscarinic agonist with more selectivity for the GI tract.
Option D (oxymetazoline, dobutamine) is incorrect as they target different receptors. Oxymetazoline is an alpha-adrenergic agonist used for nasal decongestion, while dobutamine is a beta-adrenergic agonist primarily used for cardiac support.
Understanding antagonist and agonist pairs is essential for healthcare professionals to make informed decisions when selecting medications for patients of all ages. This knowledge helps in predicting drug effects, managing adverse reactions, and optimizing therapeutic outcomes.